Erfu Niliu Pian (二氟尼柳片)二氟尼柳片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 郑州泰丰制药有限公司Chinese legal name: 郑州泰丰制药有限公司
主要成分Active Ingredients
- 二氟尼柳Erfu Niliu
药物知识说明
二氟尼柳是一种在国家药监局注册认定的药品。标注生产企业为郑州泰丰制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：郑州泰丰制药有限公司Chinese legal name: 郑州泰丰制药有限公司、郑州泰丰制药有限公司Chinese legal name: 郑州泰丰制药有限公司、郑州泰丰制药有限公司Chinese legal name: 郑州泰丰制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 二氟尼柳片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 郑州泰丰制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 郑州泰丰制药有限公司Chinese legal name: 郑州泰丰制药有限公司, 郑州泰丰制药有限公司Chinese legal name: 郑州泰丰制药有限公司, 郑州泰丰制药有限公司Chinese legal name: 郑州泰丰制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 二氟尼柳片Recorded Chinese name: 二氟尼柳片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.25g*120.25 g × 12
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 郑州泰丰制药有限公司Chinese legal name: 郑州泰丰制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20010747
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20010747
Manufacturer
Chinese legal name: 郑州泰丰制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20010747
生产企业
郑州泰丰制药有限公司(国产)
适应症
适用于类风湿性关节炎、骨关节炎、以及各种轻、中度疼痛。
用法用量
饭后口服。成人一日2次，一次0.5g，或遵医嘱。一日维持剂量不应超过1.5g。
不良反应
1．胃肠道反应：部分病人有恶心、食欲减退、腹痛、腹胀、便秘和腹泻。2．中枢神经系统反应：一般极少发生，主要有眩晕、头痛、嗜睡、失眠，症状较轻，很少需要中断治疗。3．偶见皮疹、水肿、鼻炎、短暂视觉障碍。
禁忌
1．对本品或其他非甾体抗炎药过敏者包括阿斯匹林；2．活动期消化性溃疡患者；3．严重肝、肾功能损害的病人。
注意事项
1．出血时间延长倾向者和有消化道疾病史患者慎用。2．心功能不全，高血压或其他有体液贮留倾向的病人慎用，因有可能导致水肿。3．肝、肾功能不良病人应用本品时，应使用较低剂量，并严密观察，以避免药物蓄积进一步损害肝肾功能。
贮藏
密封保存。
规格
0.25g*12
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.